CPRX logo

Catalyst Pharmaceuticals (CPRX)

Profile

Full Name

Catalyst Pharmaceuticals, Inc.

Ticker Symbol

CPRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 8, 2006

Indexes

Not included

Website

http://catalystpharma.com

Employees

181

Key Details

Price

$21.45(-5.67%)

Market cap

$2.61B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$491.73M(+23.49% YoY)

Annual EPS

$1.31(+107.94% YoY)

PE ratio

16.37

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$21.45
CPRX price is $21.45

30-Day Relative Volume

1.00
CPRX 30-day relative volume is 1.00

Price Performance

Price Most recent change

-5.67%
CPRX price was down -5.67% on Apr 10, 2025

Price YTD change

+2.78%
CPRX price is up +2.78% since January 1st

Price 1-year change

+35.08%
CPRX price is up +35.08% year-on-year

Price 3-year change

+165.8%
CPRX price is up +165.8% over the past 3 years

Price Range

Price All-time high

$26.16
CPRX price is currently -18.00% below its historical high of $26.16

Price 3-year low

$6.15
CPRX price is currently +248.78% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.61B
CPRX market capitalization is $2.61 billion

Market cap 3-year change

+213.54%
CPRX market capitalization is up +213.54% over the past 3 years

Market cap All-time high

$3.13B
CPRX market capitalization is currently -16.67% below its historical high of $3.13 billion

Market cap sector rank

85.87%
CPRX market capitalization is higher than 85.87% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.9%
CPRX shares outstanding is up +2.9% year-on-year

Shares Outstanding 3-Year Change

+17.96%
CPRX shares outstanding is up +17.96% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.87
CPRX beta is 0.87

200-day SMA

$20.78
CPRX price is currently +3.22% above its 200-day simple moving average

50-day SMA

$22.67
CPRX price is currently -5.39% below its 50-day simple moving average

RSI

41.21
CPRX 14-day relative strength index is 41.21

Volume

1.00
CPRX 30-day relative volume is 1.00

ATR

$1.33
CPRX average true range is $1.33

10-day Historical Volatility

57.06%
CPRX 10-day historical volatility is 57.06%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$491.73M
CPRX annual revenue is $491.73 million

Revenue Analysts estimate

$555.22M
CPRX annual revenue is currently -11.43% lower than the consensus analysts' forecast

Revenue 1-year change

+23.49%
CPRX annual revenue is up +23.49% year-on-year

Revenue Sector rank

74.36%
CPRX annual revenue is higher than 74.36% of companies in Healthcare sector

EPS

EPS

$1.31
CPRX annual earnings per share is $1.31

EPS Analysts estimate

$2.16
CPRX annual earnings per share is currently -39.26% lower than the consensus analysts' forecast

EPS 1-year change

+107.94%
CPRX annual earnings per share is up +107.94% year-on-year

EPS Sector rank

90.34%
CPRX annual earnings per share is higher than 90.34% of companies in Healthcare sector

Profit

Gross profit

$422.89M
CPRX annual gross profit is $422.89 million

Gross margin

86.00%
CPRX annual gross profit margin is 86.00%

Operating profit

$195.12M
CPRX annual operating income is $195.12 million

Operating margin

39.68%
CPRX annual operating profit margin is 39.68%

Net income

$163.89M
CPRX annual net profit is $163.89 million

Net margin

33.33%
CPRX annual net profit margin is 33.33%

Expenses

Total expenses

$296.61M
CPRX annual total expenses is $296.61 million

Operating expenses

$227.76M
CPRX annual total operating expenses is $227.76 million

Cost of goods sold

$68.84M
CPRX annual cost of goods sold is $68.84 million

Selling, general & administrative expenses

$177.74M
CPRX annual SGA is $177.74 million

Depreciation and amortization

$37.77M
CPRX annual depreciation & amortization is $37.77 million

Interest expense

-
CPRX annual interest expense value is unknown

Income tax

$52.37M
CPRX annual income tax is $52.37 million

EBIT & EBITDA

EBIT

$195.12M
CPRX annual earnings before interest & taxes is $195.12 million

EBITDA

$232.90M
CPRX annual EBITDA is $232.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$851.41M
CPRX annual total assets is $851.41 million

Non current assets

$227.80M
CPRX annual long term assets is $227.80 million

Current assets

$623.61M
CPRX annual total current assets is $623.61 million

Cash and cash equivalents

$517.55M
CPRX annual cash & cash equivalents is $517.55 million

Accounts receivable

$65.48M
CPRX annual accounts receivable is $65.48 million

Inventory

$19.54M
CPRX annual inventory is $19.54 million

Liabilities

Total liabilities

$123.78M
CPRX annual total liabilities is $123.78 million

Long term liabilities

$3.10M
CPRX annual total long term liabilities is $3.10 million

Current liabilities

$120.68M
CPRX annual total current liabilities is $120.68 million

Accounts payable

$16.59M
CPRX annual accounts payable is $16.59 million

Debt

Total debt

$3.19M
CPRX annual total debt is $3.19 million

Total debt 1-year change

-10.37%
CPRX annual total debt is down -10.37% year-on-year

Long term debt

$2.79M
CPRX annual long term debt is $2.79 million

Short term debt

$402.00K
CPRX annual short term debt is $402.00 thousand

Equity & Capital

Shareholders equity

$727.63M
CPRX annual stockholders equity is $727.63 million

Book value

$727.63M
CPRX annual book value is $727.63 million

Retained earnings

$285.16M
CPRX annual retained earnings is $285.16 million

Working capital

$502.93M
CPRX annual working capital is $502.93 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$239.81M
CPRX annual cash flow from operations is $239.81 million

Cash from operations 1-year change

+67%
CPRX annual cash flow from operations is up +67% year-on-year

Cash from investing

-$556.00K
CPRX annual cash flow from investing activities is -$556.00 thousand

Cash from investing 1-year change

+99.81%
CPRX annual cash flow from investing activities is up +99.81% year-on-year

Cash from financing

$140.66M
CPRX annual cash flow from financing activities is $140.66 million

Cash from financing 1-year change

+1395.62%
CPRX annual cash flow from financing activities is up +1395.62% year-on-year

CAPEX

CAPEX

$556.00K
CPRX annual capital expenditures is $556.00 thousand

CAPEX 1-year change

-99.32%
CPRX annual capital expenditures is down -99.32% year-on-year

Free Cash Flow

Free cash flow

$239.25M
CPRX annual free cash flow is $239.25 million

Free cash flow 1-year change

+286.79%
CPRX annual free cash flow is up +286.79% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

86.00%
CPRX annual gross profit margin is 86.00%

Operating margin

39.68%
CPRX annual operating profit margin is 39.68%

Net margin

33.33%
CPRX annual net profit margin is 33.33%

ROA & ROE

ROA

24.80%
CPRX annual return on assets is 24.80%

ROE

29.38%
CPRX annual return on equity is 29.38%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

16.37
CPRX price to earnings ratio is 16.37

PE ratio Sector rank

29.9%
CPRX price to earnings ratio is higher than 29.9% of companies in Healthcare sector

PB Ratio

PB ratio

3.58
CPRX price to book ratio is 3.58

PB ratio Sector rank

77.8%
CPRX price to book ratio is higher than 77.8% of companies in Healthcare sector

PS Ratio

PS ratio

5.30
CPRX price to sales ratio is 5.30

PS ratio Sector rank

68.46%
CPRX price to sales ratio is higher than 68.46% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.09B
CPRX enterprise value is $2.09 billion

Enterprise value Sector rank

83.02%
CPRX enterprise value is higher than 83.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

8.98
CPRX EV/EBITDA is 8.98

EV/EBITDA Sector rank

81.16%
CPRX EV/EBITDA is higher than 81.16% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.17
CPRX annual current ratio is 5.17

Quick ratio

5.01
CPRX annual quick ratio is 5.01

Leverage

Debt to equity

0.00
CPRX annual debt to equity ratio is 0.00

Interest coverage ratio

-
CPRX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

6
CPRX piotroski f-score is 6

Altman Z-Score

15.14
CPRX altman z-score is 15.14

Analyst ratings

Recent major analysts updates

Mar 3, 25 Baird
Outperform
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 27, 25 Stephens & Co.
Overweight
Feb 4, 25 Baird
Outperform
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 9, 25 B of A Securities
Buy
Nov 18, 24 Stephens & Co.
Overweight
Nov 11, 24 Truist Securities
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

LFST logo
LifeStance Health (LFST)
Concentra Group Holdings Parent (CON)
GeneDx Holdings (WGS)
SWTX logo
SpringWorks Therapeutics (SWTX)
ZLAB logo
Zai Lab Limited (ZLAB)
TMDX logo
TransMedics (TMDX)
SGRY logo
Surgery Partners (SGRY)
MRUS logo
Merus NV (MRUS)
NVST logo
Envista Holdings (NVST)
  • What is the ticker symbol for Catalyst Pharmaceuticals?
  • Does Catalyst Pharmaceuticals pay dividends?
  • What sector is Catalyst Pharmaceuticals in?
  • What industry is Catalyst Pharmaceuticals in?
  • What country is Catalyst Pharmaceuticals based in?
  • When did Catalyst Pharmaceuticals go public?
  • Is Catalyst Pharmaceuticals in the S&P 500?
  • Is Catalyst Pharmaceuticals in the NASDAQ 100?
  • Is Catalyst Pharmaceuticals in the Dow Jones?
  • When was Catalyst Pharmaceuticals's last earnings report?
  • When does Catalyst Pharmaceuticals report earnings?
  • Should I buy Catalyst Pharmaceuticals stock now?

What is the ticker symbol for Catalyst Pharmaceuticals?

The ticker symbol for Catalyst Pharmaceuticals is NASDAQ:CPRX

Does Catalyst Pharmaceuticals pay dividends?

No, Catalyst Pharmaceuticals does not pay dividends

What sector is Catalyst Pharmaceuticals in?

Catalyst Pharmaceuticals is in the Healthcare sector

What industry is Catalyst Pharmaceuticals in?

Catalyst Pharmaceuticals is in the Biotechnology industry

What country is Catalyst Pharmaceuticals based in?

Catalyst Pharmaceuticals is headquartered in United States

When did Catalyst Pharmaceuticals go public?

Catalyst Pharmaceuticals's initial public offering (IPO) was on November 8, 2006

Is Catalyst Pharmaceuticals in the S&P 500?

No, Catalyst Pharmaceuticals is not included in the S&P 500 index

Is Catalyst Pharmaceuticals in the NASDAQ 100?

No, Catalyst Pharmaceuticals is not included in the NASDAQ 100 index

Is Catalyst Pharmaceuticals in the Dow Jones?

No, Catalyst Pharmaceuticals is not included in the Dow Jones index

When was Catalyst Pharmaceuticals's last earnings report?

Catalyst Pharmaceuticals's most recent earnings report was on Feb 26, 2025

When does Catalyst Pharmaceuticals report earnings?

The next expected earnings date for Catalyst Pharmaceuticals is May 8, 2025

Should I buy Catalyst Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page